These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6429995)

  • 1. An acquired inhibitor of factor XIII with a qualitative abnormality of fibrin cross-linking.
    Fear JD; Miloszewski KJ; Losowsky MS
    Acta Haematol; 1984; 71(5):304-9. PubMed ID: 6429995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA.
    Fukue H; Anderson K; McPhedran P; Clyne L; McDonagh J
    Blood; 1992 Jan; 79(1):65-74. PubMed ID: 1370210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An acquired inhibitor to factor XIII.
    McDevitt NB; McDonagh J; Taylor HL; Roberts HR
    Arch Intern Med; 1972 Nov; 130(5):772-7. PubMed ID: 5083419
    [No Abstract]   [Full Text] [Related]  

  • 4. An inhibitor of activated factor XIII, inhibiting fibrin cross-linking but not incorporation of amine into casein.
    Godal HC; Ly B
    Scand J Haematol; 1977 Nov; 19(5):443-8. PubMed ID: 594661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood coagulation factor XIII and fibrin stabilization (author's transl)].
    Rasche H
    Klin Wochenschr; 1975 Dec; 53(24):1137-45. PubMed ID: 765611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrin cross-linking in congenital factor XIII deficiency.
    Rodeghiero F; Barbui T
    J Clin Pathol; 1980 May; 33(5):434-7. PubMed ID: 7400341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrin-stabilizing factor inhibitors. IX. An inhibitor assay method based on SDS-disc gel electrophoresis.
    Hoffmann KJ; Ljunggren C; Stenberg P; Nilsson JL
    Acta Pharm Suec; 1973 Sep; 10(4):269-76. PubMed ID: 4759353
    [No Abstract]   [Full Text] [Related]  

  • 8. Incomplete fibrin formation and highly elevated Factor XIII activity in multiple myeloma.
    Klingemann HG; Egbring R; Havemann K
    Scand J Haematol; 1981 Oct; 27(4):253-62. PubMed ID: 6810448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inhibitor to fibrin stabilizing factor (FSF, factor XIII).
    Godal HC
    Scand J Haematol; 1970; 7(1):43-8. PubMed ID: 5447956
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitation of factor XIII by SDS polyacrylamide gel electrophoresis.
    Godal HC; Gravem K; Brosstad F; Nyvold N
    Thromb Res; 1984 Sep; 35(5):577-82. PubMed ID: 6484899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reliability of simple examination methods for the measurement of fibrin stabilization and factor XIII activity].
    Popat D; Weber G; Wenzel E
    Med Welt; 1972 Sep; 23(40):1387-9. PubMed ID: 4655580
    [No Abstract]   [Full Text] [Related]  

  • 12. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleeding tendency caused by IgG inhibitor to factor XIII, treated successfully by cyclophosphamide.
    Nakamura S; Kato A; Sakata Y; Aoki N
    Br J Haematol; 1988 Mar; 68(3):313-9. PubMed ID: 3258529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding disorder with abnormal wound healing, acid-soluble clots and normal factor XIII.
    Ragaz S; Kemp G; Furlan M; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):537-41. PubMed ID: 1037151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebral haemorrhage due to acquired factor XIII inhibitor--successful response to factor XIII concentrate.
    Daly HM; Carson PJ; Smith JK
    Blood Coagul Fibrinolysis; 1991 Aug; 2(4):507-14. PubMed ID: 1768763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A microtiter plate assay for factor XIII A-chain-fibrin interactions.
    Achyuthan KE; Santiago MA; Greenberg CS
    Anal Biochem; 1994 May; 219(1):43-8. PubMed ID: 8059954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XIII in human plasma and platelets.
    McDonagh J; McDonagh RP; Delâge JM; Wagner RH
    J Clin Invest; 1969 May; 48(5):940-6. PubMed ID: 5780202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coagulation physiology research in a new coagulation disorder. Deficiency of a fibrin-stabilizing factor].
    DUCKERT F; JUNG E; SHMERLING DH
    Schweiz Med Wochenschr; 1961 Sep; 91():1139-40. PubMed ID: 13888166
    [No Abstract]   [Full Text] [Related]  

  • 19. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
    Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of fibrin-stabilizing factor on the subunit structure of human fibrin.
    Schwartz ML; Pizzo SV; Hill RL; McKee PA
    J Clin Invest; 1971 Jul; 50(7):1506-13. PubMed ID: 5090065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.